FGF21 and Hepatic steatosis: A recent paper by Guo et al. [90] using transcriptional analysis demonstrated that KD improves hepatic steatosis via FGF21 and its receptor klotho (KLB) pathway activation in a murine model, confirming the crucial role of the FGF21 pathway in hepatic fat reduction during KD [91].